Global and India Nanotechnology-based Drug Delivery Systems Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global and India Nanotechnology-based Drug Delivery Systems Market Report & Forecast 2024-2034
Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
The global Nanotechnology-based Drug Delivery Systems revenue was US$ 5019 million in 2022 and is forecast to a readjusted size of US$ 9857 million by 2029 with a CAGR of 10.0% during the review period (2024-2034).
In India, the Nanotechnology-based Drug Delivery Systems revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2024-2034.
The Nano-based Drug Delivery System Market is driven by the demand for more effective and targeted drug delivery methods. Nano-based systems offer improved drug solubility, bioavailability, and reduced side effects. However, a significant challenge is the complexity of nanotechnology and the need for rigorous safety assessments and regulatory approvals. Ensuring the safety and biocompatibility of nano-based drug delivery systems is crucial. Additionally, competition in the market and cost considerations pose challenges, necessitating a balance between affordability and the development of advanced nano-based drug delivery technologies to meet the evolving needs of the pharmaceutical industry while ensuring patient well-being.
This report focuses on global and India Nanotechnology-based Drug Delivery Systems market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2024, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Nanotechnology-based Drug Delivery Systems will continue to grow rapidly in the future.
Global Nanotechnology-based Drug Delivery Systems Scope and Market Size
Nanotechnology-based Drug Delivery Systems market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Nanotechnology-based Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Nanotechnology-based Drug Delivery Systems market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.
Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Pacira
Luye Pharma
Leadiant Biosciences
Ipsen
Sayre Therapeutics
Jazz
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences
Segment by Type
Liposomes Drugs
Lipid Nanoparticle Drugs
Hospital
Retail Pharmacy
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Nanotechnology-based Drug Delivery Systems definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Nanotechnology-based Drug Delivery Systems companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Nanotechnology-based Drug Delivery Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nanotechnology-based Drug Delivery Systems revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
The global Nanotechnology-based Drug Delivery Systems revenue was US$ 5019 million in 2022 and is forecast to a readjusted size of US$ 9857 million by 2029 with a CAGR of 10.0% during the review period (2024-2034).
In India, the Nanotechnology-based Drug Delivery Systems revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2024-2034.
The Nano-based Drug Delivery System Market is driven by the demand for more effective and targeted drug delivery methods. Nano-based systems offer improved drug solubility, bioavailability, and reduced side effects. However, a significant challenge is the complexity of nanotechnology and the need for rigorous safety assessments and regulatory approvals. Ensuring the safety and biocompatibility of nano-based drug delivery systems is crucial. Additionally, competition in the market and cost considerations pose challenges, necessitating a balance between affordability and the development of advanced nano-based drug delivery technologies to meet the evolving needs of the pharmaceutical industry while ensuring patient well-being.
This report focuses on global and India Nanotechnology-based Drug Delivery Systems market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2024, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Nanotechnology-based Drug Delivery Systems will continue to grow rapidly in the future.
Global Nanotechnology-based Drug Delivery Systems Scope and Market Size
Nanotechnology-based Drug Delivery Systems market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Nanotechnology-based Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Nanotechnology-based Drug Delivery Systems market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.
By Company
Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Pacira
Luye Pharma
Leadiant Biosciences
Ipsen
Sayre Therapeutics
Jazz
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences
Segment by Type
Liposomes Drugs
Lipid Nanoparticle Drugs
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Nanotechnology-based Drug Delivery Systems definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Nanotechnology-based Drug Delivery Systems companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Nanotechnology-based Drug Delivery Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nanotechnology-based Drug Delivery Systems revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices